Search - tctmd.com

Displaying 81 - 100 of 134

Sort: Relevancy | Date

News Industry News

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 29, 2013

News Industry News

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Industry News

FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries

September 24, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

News Industry News

Medtronic Submits First 'PMA' Module for IN.PACT Admiral Drug-Eluting Balloon

August 15, 2013

News Industry News

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 04, 2013

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

News Industry News

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

May 23, 2013

News Industry News

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

May 22, 2013

News Industry News

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

May 21, 2013

News Industry News

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 21, 2013

News Industry News

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

March 09, 2013

News Industry News

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

February 14, 2013

News Industry News

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

December 17, 2012

News Industry News

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

December 16, 2012

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

Advertisement

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

Medtronic Submits First 'PMA' Module for IN.PACT Admiral Drug-Eluting Balloon

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content